
Who Sunscreens an Elephant?
But certain modern animals have sun problems that natural selection can't easily solve. Some reside at zoos that can't perfectly replicate their habitat; others live at latitudes that their ancestors didn't experience. Others spend too much time sunbathing in a living-room window, or sport sparse or light-colored fur or hair because their domesticators liked the way it looked. For these animals, people have come up with a shorter-term solution: sunscreen.
If, that is, a creature is willing to accept the treatment. Indu, an Asian elephant who lived at the Phoenix Zoo, was game. A few years ago, Heather Wright, one of the zookeepers, noticed the tops of Indu's ears pinking, peeling, and flaking in the summer heat, much like her human keepers' did. So her caretakers picked up some zinc-oxide-based sunblock—specially formulated for sensitive (human) skin—and dabbed it on the elephant. Indu, to be fair, was used to a level of care most wild animals don't enjoy. 'We had already been applying lotion for dryness,' Wright told me. The elephant knew the drill: Once in the barn, she'd lumber up to a window with an opening for her ear and stick the appendage through.
As far as zoo staff members could tell, the treatment helped. 'There's nothing magical' about other animals' skin, Leslie Easterwood, a large-animal veterinarian at Texas A&M University, told me: Bake it in the sun, and it will burn. Scientists have spotted whales suffering from sunburns; cats, dogs, horses—even alpacas, turtles, and penguins—can develop all kinds of skin cancers. Pigs, in particular, 'have skin most similar to humans,' Mitchell Song, a veterinary dermatologist based in Arizona told me. At Zoo Miami, keepers have spread mud on older, arthritic wild pigs who can't wallow as well as they did in their youth; they've also applied sunscreen to a babirusa, a species of swine native to Indonesia's forests, and to a Kunekune pig, Gwen Myers, the zoo's chief of animal health, told me.
In some sunny places, vets commonly recommend sunscreen for pets and other domesticated creatures, especially light-colored dogs and horses. Steve Valeika, a veterinarian in North Carolina, advises the same for 'white cats that go outside.' This particular conundrum is one of our own making. 'You don't see a lot of white-skinned animals in the wild,' Anthea Schick, a veterinary dermatologist in Tempe, Arizona, told me. Only thanks to generations of selective breeding have they become a frequent presence in and around people's homes.
Of course, to sunscreen your pet, you have to … sunscreen your pet. Some pet owners, vets told me, are definitely flummoxed by the suggestion: 'It's not widely discussed,' Schick told me. Vets are more unified in recommending teeth brushing for cats—and most cat owners still just decide they'd rather not. But some animals would certainly benefit from block: Schick told me she's seen her fair share of badly burned dogs, especially after long bouts of sunbathing that scorch their bellies. 'We see a lot of sun-induced skin cancers that could be avoided,' she said. Pit bulls, Dalmatians, and other short-haired breeds are especially vulnerable; even long-haired white cats are sensitive around their eyes, their nose, and the tips of their ears. And Easterwood estimates that the majority of paint horses, left unprotected, will eventually develop skin issues. Squamous-cell-carcinoma cases make up the majority of her workload: 'I see it every single day,' she said.
The vets I spoke with generally agreed: Don't bother with sprays, which a lot of animals find annoying or downright terrifying; reapply often, and well; it is way, way, way harder to sunscreen a cat than a dog, though some brave souls manage it. But although some vets recommended human sunscreens, formulated for kids or sensitive skin, others told me they preferred blends marketed for animals. (The FDA has dubbed just one pet sunscreen, made by a company called Epi-Pet and marketed to dogs and horses, 'FDA compliant'—not the same as FDA approval, which requires rigorous safety testing.) Several warned against zinc oxide, which can be toxic to animals if ingested in large quantities; others felt that zinc oxide was worth the risk, unless administered to a tongue-bathing cat.
Regardless of the product they're offered, most animals generally aren't as eager as Indu to subject themselves to a human-led sun-protection ritual. And even she was usually plied with a five-gallon bucket of fruits and vegetables while her keepers tended her ears. At Zoo Miami, keeper Madison Chamizo told me she and her colleagues had to spend months training an okapi—an African mammal closely related to a giraffe—to accept caretakers gently scrubbing sunscreen onto her back with a modified Scotch-Brite dishwand, after she lost some patches of hair on her back to a fungal infection. But for creatures in very sunny parts of the world, the alternatives are, essentially, being cooped up indoors, kept away from windows, or wrestled into full-body sunsuits. (Some dogs don't mind; cats, once again, are unlikely to comply.)
And some sun-related problems, sunscreen can't fix. Gary West, the Phoenix Zoo's vet, told me he suspects that UV glare has caused eye inflammation in some of his animals; Myers, in Miami, worries about the sensitive skin around some species' eyes. 'They're not really going to wear sunglasses for us,' Myers told me. So she and her colleagues have started to wonder: 'Gosh, is this an animal that we could put a sun visor on?'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time Business News
a day ago
- Time Business News
Breakthrough Innovations Transforming Lung Cancer Diagnosis and Treatment
Lung cancer is a type of cancer that begins in the lungs, often caused by smoking, exposure to pollutants, genetic factors or commercial threats. Lung cancer market is increasing due to growing global lung cancer rate, awareness and increase in screening programs, progress in clinical technologies (such as low -dosage CT scans and liquid biopsy) and increasing remedies and development of targeted remedies and immunotherapy. Additionally, better healthcare in aging population and emerging areas is promoting infrastructure and early detection and demand for effective treatment solutions. Key Growth Drivers and Opportunities Growing Global Lung Cancer Rate: Rising global lung cancer rate is a major driver of lung cancer market development, as it increases the demand for early identity, accurate diagnosis and effective treatment solutions. One of the major causes of cancer-related deaths worldwide with lung cancer, healthcare systems are making heavy investments in advanced screening tools such as low-dosage CT scans and biomarker-based diagnosis to enable the first diagnosis. At the same time, rising patient numbers are accelerating the development and adoption of innovative remedies including targeted drugs and immunotherapy. The burden of growing disease also attracts more research funds and industry investment, further fuel to market expansion. Challenges The lung cancer market faces several borders, including advanced diagnosis and high cost of targeted treatments, which can limit access to areas with especially low and moderate income. Delayed diagnosis also disrupts the results of treatment due to lack of awareness, limited screening programs and non-specific initial symptoms. Additionally, the challenge of complex regulatory routes, delayed stage patients, and the challenge of managing side effects from therapy disrupts the market growth despite technological progress. Innovation and Expansion EQUAL Study Launches High-Risk Group Lung Cancer Screening Trial In May 2025, Researchers at the Dana-Farber Cancer Institute have begun testing a new, in-house blood test in an effort to screen for lung cancer and identify those who are at a higher risk of developing the disease even if they have never used tobacco. Epidermal growth factor receptor (EGFR) gene mutations can be common in the Asian and Hispanic/Latinx populations, which is the subject of the EQUAL (EGFR ctDNA Quantitative Assessment for Lung Cancer screening in Asian and Latinx populations) study. Possessing this mutation increases the risk of lung cancer because EGFR type mutations are linked to the illness. Additionally, the number of cancer diagnoses among Asian or Hispanic/Latinx individuals is increasing at a faster rate. With India's First LungLife Screening Program to Fight Lung Cancer, Apollo Cancer Centre Sets the Standard In March 2025, India's first LungLife Screening Program for early lung cancer diagnosis has been introduced by Apollo Cancer Centres (ACCs), a pioneer in state-of-the-art cancer care. Lung cancer, which makes up 5.9% of all malignancies and 8.1% of cancer-related deaths in India, is the target of this ground-breaking project. Early identification increases the survival rate and improves treatment results (LINK). Low-dose computed tomography (LDCT) early screening can greatly increase survival chances and help with early diagnosis. However, almost 80% of high-risk patients have never spoken to their doctors about screening. To allow early detection and save lives, it is imperative to improve knowledge and communication regarding lung cancer screening, particularly among high-risk individuals. Inventive Sparks, Expanding Markets The key players operating the lung cancer market include AstraZeneca, Hoffman La Roche, Eli Lilly and Company, Pfizer Inc., Merck & Co., Amgen Inc., Novartis AG, Johnson & Johnson, Teva Pharmaceuticals Industries Ltd., Bristol-Myers Squibb Company. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS


Newsweek
a day ago
- Newsweek
Tiny 'Flowers' Offer New Hope Against Alzheimer's and Parkinson's
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Tiny, metallic, flower-shaped nanoparticles may offer fresh hope for patients with neurodegenerative diseases like Alzheimer's and Parkinson's. This is the conclusion of researchers from Texas A&M University, who found that the so-called nanoflowers can protect and heal brain cells. The do this by promoting the health and turnover of mitochondria—the oft-dubbed "powerhouses of the cell" which are responsible for turning food into energy. While this process is essential for life, the mitochondria also produce waste in the process—including so-called "reactive oxygen species"—which can damage cells. The finding could pave the way for new treatments for neurological diseases that address the underlying root causes—in this case mitochondrial health and oxidative stress—instead of just managing symptoms. "We expect that our drug can reverse neuronal damage and consequently reverse neurodegeneration," study lead and biochemist professor Dmitry Kurouski told Newsweek. Alzheimer's is the most common neurodegenerative disease with Parkinson's coming in second—and promising new treatments are much sought after. In fact, more than seven million Americans are living with Alzheimer's, a figure projected to rise to nearly 13 million by 2050, according to the Alzheimer's Association. Meanwhile, around 1.1 million people in the U.S. are living with Parkinson's, expected to rise to 1.2 million by 2030, according to Parkinson's Foundation. Alongside potentially helping combat Alzheimer's and Parkinson's, Kurouski said, "it is important to mention that similar reversing effects could be expected in other pathologies including acute brain and spinal cord injuries." Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Doctor and older patient smile while looking at phone results, with inserted image of nanoflowers overlayed in corner. Lacheev / iStock / Getty Images Plus / Journal of Biological Chemistry In their study, Kurouski and colleagues explored—in a petri dish in the lab—how nanoflowers affect both the brain's nerve cells, or 'neurons', and the star-shaped 'astrocytes' that support them. Within 24 hours of treatment, the team saw a "dramatic" drop in the levels of ROS, accompanied by signs of improved mitochondrial function. "Even in healthy cells, some oxidative stress is expected. But the nanoflowers seem to fine-tune the performance of mitochondria, ultimately bringing the levels of their toxic byproducts down to almost nothing," Kurouski explained. Having assessed the effects on individual cells, the researchers next tested the impact of the nanoflowers on whole creatures—specifically a species of worm, C. elegans, which is commonly used as a model organism in neurological research. The team found that, on average, worms treated with one specific flavor of nanoflower survived for days longer than their untreated counterparts (which typically live for around 18 days) and were less likely to die during the early stages of their lives. "These nanoflowers look beautiful under a microscope, but what they do inside the cell is even more impressive," Kurouski said in a statement. "By improving the health of brain cells, they help address one of the key drivers of neurodegenerative diseases that have long resisted therapeutic breakthroughs." With more research needed before clinical trials could be conducted on humans, Kurouski says he plans to undertake further studies in more complex animal models. The team are also exploring practical concerns towards clinical applications. "We are currently working on finding the best way to administrate the drug. We anticipate that internasal spray will be the best solution," Kurouski said. The biochemist stressed that he is keen to make sure the nanoflowers are safe, effective and have clear mechanism of action—but, he concluded, he thinks they could be a "new class of therapeutics" with "incredible potential." Do you have a health story to share with Newsweek? Do you have a question about the study? Let us know via health@ Reference Mitchell, C. L., Matveyenka, M., & Kurouski, D. (2025). Neuroprotective properties of transition metal dichalcogenide nanoflowers alleviate acute and chronic neurological conditions linked to mitochondrial dysfunction. Journal of Biological Chemistry, 301(5).


Business Upturn
a day ago
- Business Upturn
Merck Foundation Together with African and Asian First Ladies Mark ‘World Assisted Reproductive Technology Day' 2025 Through Their ‘More Than a Mother' Campaign
Merck Foundation , the philanthropic arm of Merck KGaA Germany, marks 'World ART (Assisted Reproductive Technology) Day 2025′ together with African and Asian First Ladies, who are also the Ambassadors of 'Merck Foundation More Than a Mother' Campaign, by building and advancing fertility care capacity in Africa and Asia. Business Wire India Merck Foundation has made history by training the first local Embryologists and Reproductive & Fertility Experts in many countries such as The Gambia, Liberia, Burundi, Guinea, Chad, Niger, Sierra Leone, Malawi, and Congo. Moreover, supported training for the staff of First Public IVF Centers in Rwanda, Burundi, Ethiopia, Niger, Bangladesh, and Myanmar. Merck Foundation launched 'More Than a Mother Animation Film' that raises awareness about breaking infertility stigma, infertility prevention and male infertility, watch here: Merck Foundation , the philanthropic arm of Merck KGaA Germany, marks 'World ART (Assisted Reproductive Technology) Day 2025′ together with African and Asian First Ladies, who are also the Ambassadors of 'Merck Foundation More Than a Mother' Campaign, by building and advancing fertility care capacity in Africa and Asia. Senator, Dr. Rasha Kelej, CEO of Merck Foundation and President of 'More Than a Mother' emphasized, "At Merck Foundation we mark World Assisted Reproductive Technology Day by building Fertility and Reproductive Care capacity and empowering infertile women by improving their access to information, change of mindset and quality & equitable fertility care across Africa & Asia as part of our 'More than a Mother' campaign. I am very proud to share that we have provided till today 716 scholarships of Embryology, Fertility and Sexual & Reproductive care to young doctors from 41 countries in Africa and Asia to be the local Embryologists, Fertility & Reproductive care experts in their countries. Moreover, many of our Alumni were trained to be the first local experts in their countries where they never had even a single local embryologist or fertility specialist before our program such as; The Gambia, Burundi, Guinea, Chad, Niger, Sierra Leone, Liberia, Malawi, Congo, Mozambique and more. Together with African First Ladies, and other important partners, we are making history and reshaping the landscape of fertility & Reproductive care across Africa and beyond,' added Dr. Kelej. Merck Foundation 'More Than a Mother' is a powerful campaign that defines interventions to build quality and equitable Reproductive and Fertility Care Capacity, Break Infertility Stigma and Raise Awareness about Infertility Prevention and Male Infertility. Merck Foundation has provided 2280 scholarships for doctors from 52 countries in 44 critical and underserved medical specialties. 'To give an overview, out of our total 716 scholarships for Fertility and Reproductive care, we have provided more than 324 Scholarships for clinical and practical training to Fertility Specialists and Embryologists, and more than 392 Scholarships for PG Diploma and Master Degree in Sexual and Reproductive Medicine, Clinical Psychiatry, Women's Health, Biotechnology of Human Assisted Reproduction & Embryology, Urology, Laparoscopic Surgical skills and Family Medicine to doctors from 41 countries across Africa and Asia. We are proud of this achievement,' added Dr. Rasha Kelej. According to WHO data, more than 180 million couples in developing countries – that is 1 in every 4 couple, suffer from infertility. In many cultures in Africa, infertility is a huge stigma. Women are solely blamed for failing to conceive and the social stigma of childlessness, especially for women leads to isolation and stigmatization and results in discrimination and ostracism. This mostly also leads to divorce or physical or psychological violence. As a part of 'More Than a Mother' Campaign, Merck Foundation has launched many initiatives to break this stigma and create a culture shift. Merck Foundation has also been empowering childless and infertile women through their 'Empowering Berna' initiative under their 'More Than a Mother' movement. This initiative helps women who cannot be treated for infertility anymore by helping them get trained to establish small businesses so that they can be independent and rebuild their lives. Through 'Empowering Berna', the lives of many infertile women have been transformed in many African countries like Kenya, Uganda, Nigeria, Central African Republic, Niger, Malawi, and many more. 'It's all about giving every woman the respect and the help she deserves to lead a fulfilling life, with or without a child,' added Dr. Kelej. Moreover, Merck Foundation has trained more than 3700 media representatives from more than 35 countries to raise community awareness and break the stigma around infertility and infertile and childless women. Merck Foundation in partnership with Africa's First Ladies, has also launched 'More Than Mother' Children's storybook to emphasize strong family values of love and respect from a young age which will reflect on eliminating the stigma of infertility and the resulted domestic violence in the future. The storybooks have been localized for each country and in three languages, English, French and Portuguese to better connect with the young readers. The book has also been adapted to an animation film. Watch More Than a Mother Animation Film here: Merck Foundation's pan African TV program 'Our Africa', that is conceptualized, produced, directed, and co-hosted by Senator, Dr. Rasha Kelej, CEO of Merck Foundation and features African Fashion Designers, Singers, and prominent experts from various domains with the aim to raise awareness and create a culture shift across Africa, has many episodes dedicated to raise awareness about infertility and breaking infertility stigma. Watch the episodes here: Episode 3: Episode 5: Episode 10: Merck Foundation has also released about 30 songs, many of these songs have been created with the aim to break the infertility stigma, as a part of their 'More Than a Mother' campaign. Listen to some of the songs here: Watch, share & subscribe to the 'Plus qu'une MERE' composed and sung by Ms. Lucky-Lou, the daughter of The President and The First Lady of Burundi: Watch, share & subscribe to the 'More Than a Mother' song by Cwesi Oteng and Adina from Ghana: Watch, share & subscribe to the 'More Than a Mother' song by Zambian Soul Singer Wezi: Watch, share & subscribe to the 'More Than a Mother' song by Sunita Daffeh from the Gambia: Listen to all 'More than a Mother' songs here: 'To address this important issue of breaking infertility stigma and also a wide range of other social issues, we annually launch Merck Foundation 'More Than a Mother' Awards in partnership with African First Ladies. I would also like to invite the African Community of Media, Fashion, Filmmaking, and Musicians, students, and potential talents in these fields to apply for the awards this year by sharing their creative work on [email protected] , ' concluded Senator, Dr. Rasha Kelej. Click on the link below to Download Merck Foundation App Join the conversation on our social media platforms below and let your voice be heard! Facebook: Merck Foundation X: @MerckFoundation YouTube: MerckFoundation Instagram: Merck Foundation Threads: Merck Foundation Flickr: Merck Foundation Website: